Goldman Sachs initiates Insmed stock coverage with buy rating, $188 target

🌐 Investing.com (CY) —
Goldman Sachs initiates Insmed stock coverage with buy rating, $188 target

AI Summary

Goldman Sachs has initiated coverage on Insmed stock with a buy rating and set a target price of $188, signaling confidence in the company's market potential.

Markets Deals Goldman Sachs Insmed stock coverage buy rating target price

Read original source →